The “Bolar” Exemption in Europe
Dr Holger Tostmann elaborates the two mechanisms for exemption of medicinal products from patent protection which exist in Europe: the so-called "research exemption" and the "Bolar exemption". This article has been published in the fall newsletter of AIPLA's Chemical Practice Chronicles.
lesen
Dr. Holger Tostmann
